122 related articles for article (PubMed ID: 38169132)
21. Comparison of quantitative susceptibility mapping methods for iron-sensitive susceptibility imaging at 7T: An evaluation in healthy subjects and patients with Huntington's disease.
Yao J; Morrison MA; Jakary A; Avadiappan S; Chen Y; Luitjens J; Glueck J; Driscoll T; Geschwind MD; Nelson AB; Villanueva-Meyer JE; Hess CP; Lupo JM
Neuroimage; 2023 Jan; 265():119788. PubMed ID: 36476567
[TBL] [Abstract][Full Text] [Related]
22. Harmonic field extension for QSM with reduced spatial coverage using physics-informed generative adversarial network.
Jung S; Jeon S; Gho SM; Lee HJ; Jung KJ; Kim DH
Neuroimage; 2024 Mar; 288():120528. PubMed ID: 38311125
[TBL] [Abstract][Full Text] [Related]
23. Technical Note: Optimization of quantitative susceptibility mapping by streaking artifact detection.
Wu ML; Wang CK; Lin PY; Chao TC
Med Phys; 2020 Nov; 47(11):5715-5722. PubMed ID: 32945538
[TBL] [Abstract][Full Text] [Related]
24. Streaking artifact reduction for quantitative susceptibility mapping of sources with large dynamic range.
Wei H; Dibb R; Zhou Y; Sun Y; Xu J; Wang N; Liu C
NMR Biomed; 2015 Oct; 28(10):1294-303. PubMed ID: 26313885
[TBL] [Abstract][Full Text] [Related]
25. Chaos and COSMOS-Considerations on QSM methods with multiple and single orientations and effects from local anisotropy.
Gkotsoulias DG; Jäger C; Müller R; Gräßle T; Olofsson KM; Møller T; Unwin S; Crockford C; Wittig RM; Bilgic B; Möller HE
Magn Reson Imaging; 2024 Jul; 110():104-111. PubMed ID: 38631534
[TBL] [Abstract][Full Text] [Related]
26. Phase processing for quantitative susceptibility mapping of regions with large susceptibility and lack of signal.
Fortier V; Levesque IR
Magn Reson Med; 2018 Jun; 79(6):3103-3113. PubMed ID: 29130526
[TBL] [Abstract][Full Text] [Related]
27. Background field removal for susceptibility mapping of human brain with large susceptibility variations.
Fang J; Bao L; Li X; van Zijl PCM; Chen Z
Magn Reson Med; 2019 Mar; 81(3):2025-2037. PubMed ID: 30298547
[TBL] [Abstract][Full Text] [Related]
28. Comparison of quantitative susceptibility mapping methods on evaluating radiation-induced cerebral microbleeds and basal ganglia at 3T and 7T.
Chen Y; Genc O; Poynton CB; Banerjee S; Hess CP; Lupo JM
NMR Biomed; 2022 May; 35(5):e4666. PubMed ID: 35075701
[TBL] [Abstract][Full Text] [Related]
29. Investigating the accuracy and precision of TE-dependent versus multi-echo QSM using Laplacian-based methods at 3 T.
Biondetti E; Karsa A; Thomas DL; Shmueli K
Magn Reson Med; 2020 Dec; 84(6):3040-3053. PubMed ID: 32491224
[TBL] [Abstract][Full Text] [Related]
30. Single-step calculation of susceptibility through multiple orientation sampling.
Chen L; Cai S; van Zijl PCM; Li X
NMR Biomed; 2021 Jul; 34(7):e4517. PubMed ID: 33822416
[TBL] [Abstract][Full Text] [Related]
31. Enhancing k-space quantitative susceptibility mapping by enforcing consistency on the cone data (CCD) with structural priors.
Wen Y; Wang Y; Liu T
Magn Reson Med; 2016 Feb; 75(2):823-30. PubMed ID: 25752805
[TBL] [Abstract][Full Text] [Related]
32. Multiecho complex total field inversion method (mcTFI) for improved signal modeling in quantitative susceptibility mapping.
Wen Y; Spincemaille P; Nguyen T; Cho J; Kovanlikaya I; Anderson J; Wu G; Yang B; Fung M; Li K; Kelley D; Benhamo N; Wang Y
Magn Reson Med; 2021 Oct; 86(4):2165-2178. PubMed ID: 34028868
[TBL] [Abstract][Full Text] [Related]
33. Global cerebrospinal fluid as a zero-reference regularization for brain quantitative susceptibility mapping.
Dimov AV; Nguyen TD; Spincemaille P; Sweeney EM; Zinger N; Kovanlikaya I; Kopell BH; Gauthier SA; Wang Y
J Neuroimaging; 2022 Jan; 32(1):141-147. PubMed ID: 34480496
[TBL] [Abstract][Full Text] [Related]
34. Instant tissue field and magnetic susceptibility mapping from MRI raw phase using Laplacian enhanced deep neural networks.
Gao Y; Xiong Z; Fazlollahi A; Nestor PJ; Vegh V; Nasrallah F; Winter C; Pike GB; Crozier S; Liu F; Sun H
Neuroimage; 2022 Oct; 259():119410. PubMed ID: 35753595
[TBL] [Abstract][Full Text] [Related]
35. Motion artifacts in standard clinical setting obscure disease-specific differences in quantitative susceptibility mapping.
Meineke J; Wenzel F; De Marco M; Venneri A; Blackburn DJ; Teh K; Wilkinson ID; Katscher U
Phys Med Biol; 2018 Jul; 63(14):14NT01. PubMed ID: 29897342
[TBL] [Abstract][Full Text] [Related]
36. Robust breast quantitative susceptibility mapping in the presence of silicone.
Böhm C; Stelter JK; Weiss K; Meineke J; Komenda A; Borde T; Makowski MR; Fallenberg EM; Karampinos DC
Magn Reson Med; 2023 Sep; 90(3):1209-1218. PubMed ID: 37125658
[TBL] [Abstract][Full Text] [Related]
37. Single-step quantitative susceptibility mapping with variational penalties.
Chatnuntawech I; McDaniel P; Cauley SF; Gagoski BA; Langkammer C; Martin A; Grant PE; Wald LL; Setsompop K; Adalsteinsson E; Bilgic B
NMR Biomed; 2017 Apr; 30(4):. PubMed ID: 27332141
[TBL] [Abstract][Full Text] [Related]
38. Deep learning-based quantitative susceptibility mapping (QSM) in the presence of fat using synthetically generated multi-echo phase training data.
Hanspach J; Bollmann S; Grigo J; Karius A; Uder M; Laun FB
Magn Reson Med; 2022 Oct; 88(4):1548-1560. PubMed ID: 35713187
[TBL] [Abstract][Full Text] [Related]
39. SHARQnet - Sophisticated harmonic artifact reduction in quantitative susceptibility mapping using a deep convolutional neural network.
Bollmann S; Kristensen MH; Larsen MS; Olsen MV; Pedersen MJ; Østergaard LR; O'Brien K; Langkammer C; Fazlollahi A; Barth M
Z Med Phys; 2019 May; 29(2):139-149. PubMed ID: 30773331
[TBL] [Abstract][Full Text] [Related]
40. Computed inverse MRI (CIMRI) for intrinsic brain magnetic susceptibility mapping.
Chen Z; Chen Z
Comput Biol Med; 2021 Jul; 134():104498. PubMed ID: 34051451
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
